Nanomaterials In Personalized Medicine Market Growth Outlook Reveals A CAGR Of 11.3% And A Market Value Of $674.28 Billion By 2030
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Nanomaterials In Personalized Medicine Market Growth Analysis: How Will Revenue Expand During The Forecast Period?
The market for nanomaterials in personalized medicine has experienced swift expansion in recent times. Projected figures indicate a rise from $392.97 billion in 2025 to $438.79 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.7%. This historic growth is driven by progress in genomics and molecular biology, a growing embrace of targeted treatments, broader translational medical research, access to sophisticated nanofabrication methods, and strengthened partnerships between academia and industry.
The market for nanomaterials in personalized medicine is projected to experience substantial expansion over the coming years. By 2030, its value is anticipated to reach $674.28 billion, reflecting a compound annual growth rate (CAGR) of 11.3%. This forecasted growth is driven by several factors, including a heightened demand for tailored healthcare approaches, increased funding for precision medicine initiatives, broader applications of nanomaterials in diagnostics and imaging, a stronger emphasis on reducing adverse effects from treatments, and ongoing advancements in nano-enabled medical technologies. Key trends shaping this period involve the expanded use of targeted nanomaterials for customized therapies, the deeper integration of molecular diagnostics with nanotechnology, the growing application of nanomaterials in precise drug delivery systems, the widening role of nanotechnology in regenerative medicine, and a more pronounced focus on achieving patient-specific therapeutic outcomes.
Download A Free Sample Report For Comprehensive Market Insights:
Nanomaterials In Personalized Medicine Market Growth Momentum: Which Factors Are Influencing Demand?
The growing interest in personalized medicine is expected to fuel expansion in the nanomaterials in personalized medicine market. Personalized medicine refers to a medical strategy that customizes treatments for each patient, taking into account their genetic, environmental, and lifestyle factors to enhance outcomes and improve care quality. This demand is rising due to progress in genomic technologies, which allow for the accurate detection of genetic differences and the development of tailored treatments for individuals. Within this field, nanomaterials contribute by supporting targeted, patient-specific therapies that boost treatment effectiveness and safety. They facilitate the precise administration of drugs, genes, or RNA, minimizing adverse effects and maximizing therapeutic benefits. As an example, in February 2024, the Personalized Medicine Coalition (PMC), a U.S.-based nonprofit, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable jump from 12 approvals in 2022. Consequently, the rising demand for personalized medicine is propelling the nanomaterials in personalized medicine market forward.
Nanomaterials In Personalized Medicine Market Segment Landscape And Growth Potential
The nanomaterials in personalized medicine market covered in this report is segmented –
1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles
2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery
3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods
4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines
5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions
Subsegments:
1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots
2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles
3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels
4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods
5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles
Nanomaterials In Personalized Medicine Market Trends Reshaping Industry Growth
Major firms in the nanomaterials used for personalized medicine are increasingly pursuing strategic collaborations to speed up clinical application, broaden the range of treatable conditions, and reduce the time required to bring products to market, all while complying with evolving regulatory demands. Such partnerships involve organizations pooling their specialized knowledge and assets to drive innovation and create new opportunities within personalized healthcare. For example, in May 2025, Acuitas Therapeutics Inc., a Canadian biotechnology firm, teamed up with Integrated DNA Technologies Inc., a US-based provider of genomics tools, to unveil a tailored CRISPR gene-editing therapy delivery system built on their lipid nanoparticle platform. This system was applied to treat a single infant suffering from a rare genetic disorder, incorporating precisely targeted CRISPR components, customized dosing adjustments, and swift bespoke formulation. This breakthrough enables rapid, highly individualized therapeutic approaches. It enhances treatment accuracy and patient outcomes, yet presents hurdles in scalable production, meticulous regulatory adaptation, and small-scale manufacturing.
Nanomaterials In Personalized Medicine Market Competitive Landscape: Who Are The Leading Companies?
Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.
Access The Complete Nanomaterials In Personalized Medicine Market Report:
Nanomaterials In Personalized Medicine Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
